Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumors

Treatment With the Radiolabeled Somatostatin Analog [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

International basic safety standards for protection against ionizing radiation of and for the safety of radiation sources

Gary F. Bennett · Journal of Hazardous Materials · 1996 · 710 citations

Medicine, Nuclear Engineering, Radiology +14

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 421 citations

Medicine, Nuclear Medicine, Pharmacology +14

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

Dik J. Kwekkeboom, Eric P. Krenning, Rachida Lebtahi et al. · Neuroendocrinology · 2009 · 349 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

International basic safety standards for protection against ionizing radiation and for the safety of radiation sources

Gary F. Bennett · Journal of Hazardous Materials · 1997 · 328 citations

Medicine, Nuclear Engineering, Radiology +14